Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer.

Ayumi ShikamaTakeo MinaguchiWataru TakaoYoshihiko HosokawaKeiko NishidaNobutaka TasakaAzusa AkiyamaManabu SakuraiHiroyuki OchiToyomi Satoh

Published in: International journal of clinical oncology (2019)

Patients with endometrioid histology and PS 0 should be offered SCS for recurrent EC. Prospective trials are warranted to verify this proposal.

Keyphrases